SGLT-2 Inhibitors and Circulating Progenitor Cells in Diabetes.
Sign Up to like & getrecommendations! Published in 2020 at "Cell metabolism"
DOI: 10.1016/j.cmet.2020.04.002
Abstract: Hess et al. recently hypothesized that shifts in circulating progenitor cell populations may drive cardiovascular protection by SGLT-2 inhibitors in patients with type 2 diabetes. In this Letter, Fadini challenges that interpretation and discusses previous findings… read more here.
Keywords: progenitor cells; circulating progenitor; inhibitors circulating; sglt inhibitors ... See more keywords